🇺🇸
United States · US · US:61755-014_a8be5cf0-49ba-4795-a2e5-7ea07f495958
VEOPOZ
UNIISPLATC L04AJ11
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerRegeneron Pharmaceuticals, Inc.
CountryUS (United States)
ATC codeL04AJ11
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 1
- ndc1161755014011 VIAL, SINGLE-DOSE in 1 CARTON (61755-014-01) / 2 mL in 1 VIAL, SINGLE-DOSE (61755-014-00)
Annotations
UNII (FDA Substance ID)
0JJ21K6L2I
POZELIMAB
DailyMed SPL labels
1 version tracked
Raw payload (JSON)
{
"unii": {
"unii": "0JJ21K6L2I",
"rxcui": null,
"inchikey": null,
"display_name": "POZELIMAB",
"substance_type": "protein",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAVENOUS; SUBCUTANEOUS",
"spl_meta": {
"a8d6f10e-9430-450a-a3dd-b538f9b2a308": {
"match": "brand_token",
"title": "VEOPOZ (POZELIMAB) INJECTION, SOLUTION [REGENERON PHARMACEUTICALS, INC.]",
"spl_version": "6",
"published_date": "2025-12-10"
}
},
"productid": "61755-014_a8be5cf0-49ba-4795-a2e5-7ea07f495958",
"productndc": "61755-014",
"dosage_form": "INJECTION, SOLUTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "POZELIMAB",
"proprietary_name": "VEOPOZ",
"active_ingred_unit": "mg/mL",
"application_number": "BLA761339",
"marketing_category": "BLA",
"nonproprietary_name": "Pozelimab",
"start_marketing_date": "20230818",
"active_numerator_strength": "200"
}Access this data programmatically
Query VEOPOZ and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.